Hot Springs, ARNCT06926868Now EnrollingIRB Ready

Triple-negative Breast Cancer Clinical Trial in Hot Springs, AR

Access cutting-edge triple-negative breast cancer treatment through this clinical trial at a research site in Hot Springs. Study-provided care at no cost to qualified participants.

Sponsored by Bristol-Myers Squibb

Quick Self-Assessment

See if you qualify for this Hot Springs location

Preparing your pre-screening questions...

Expert Care in Hot Springs

Access triple-negative breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related triple-negative breast cancer treatment provided free

Apply for This Hot Springs Location

Check if you qualify for this triple-negative breast cancer clinical trial in Hot Springs, AR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hot Springs

    Convenient for AR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hot Springs site if eligible
  4. 4Begin participation

About This Triple-negative Breast Cancer Study in Hot Springs

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates

Sponsor: Bristol-Myers Squibb

Who Can Participate

Inclusion Criteria

Histologically or cytologically confirmed and documented locally-advanced, recurrent inoperable, or metastatic TNBC (ER \< 1%, PgR \< 1%, HER2 IHC 0, 1+, or 2+ with FISH negative for HER2 gene amplification) or ER-low, HER2-negative BC (ER and / or PgR 1% to 10%, HER2 IHC 0, 1+, or 2+ with FISH negative for HER2 gene amplification) per ASCO/CAP criteria, based on the most recently analyzed biopsy or other pathology specimen.
Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
Patients with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 or an anti-PD-L1 due to either one of the following criteria:.
Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of SoC.
Has experienced disease relapse between 6 to 12 months after the completion of (neo)ad

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hot Springs?

Yes, this clinical trial (NCT06926868) has an active research site in Hot Springs, AR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Triple-negative Breast Cancer Treatment Options in Hot Springs, AR

If you're searching for triple-negative breast cancer treatment options in Hot Springs, AR, this clinical trial (NCT06926868) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hot Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced triple-negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all triple-negative breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Hot Springs, AR

See all breast cancer clinical trials recruiting in Hot Springs — not just this study.

Browse Breast Cancer Trials in Hot Springs →

Browse More Trials by Condition

Breast Cancer TrialsTriple Negative Breast Cancer TrialsAnkylosing Spondylitis TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Hot Springs?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hot Springs, AR